Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Recruiting · NCT05116072 · Registry updated 2025-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula | Neoplasms by Histologic Type, adenocarcinoma, ampulla of vater adenocarcinoma, carcinoma, duodenal adenocarcinoma, epithelial neoplasm, neoplasm, pancreatic adenocarcinoma | Recruiting | Phase 1 / Phase 2 | 2025-09-25 | NCT05116072 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ministry of Health, France | 84 |
| University Hospital, Lille | 194 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hop Claude Huriez Chu Lille | Lille | France | 18 |